Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Biotechwantabe who wrote (3078)	8/17/2020 12:29:01 AM
From: CuttingEdge Bio	Read Replies (1) \| Respond to of 3557

Slow and ineffective testing is a nationwide failure that has resulted in a poor response to the virus. Testing could have been a powerful mitigation tool as non pharmaceutical intervention. Instead it's a nearly useless diagnostic, except after peak outbreak has long past and caseload comes down to manageable levels. Even then, it's just for data purposes. "We currently have _% positivity in _ State." Whoopity do. When/if case numbers and positivity will go up again, testing is the same as it was before. It will tell you what's happening. Nothing more. And then when the testing capacity is overrun again, and turnaround times become a week or more again, making it a useless diagnostic, it will tell you how screwed you are at that particular time. Great to know! We can be confident from data about how screwed we are, rather than just getting a sense that we are currently screwed. It seems that Regeneron not only had to invent a drug to treat this disease but also invent a rapid test to run its trials with.